These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 962995)

  • 1. Distribution of survival times of 12,000 head and neck cancer patients who died with their disease.
    Mould RF; Hearnden T; Palmer M; White GC
    Br J Cancer; 1976 Aug; 34(2):180-90. PubMed ID: 962995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A test of several parametic statistical models for estimating success rate in the treatment of carcinoma cervix uteri.
    Mould RF; Boag JW
    Br J Cancer; 1975 Nov; 32(5):529-50. PubMed ID: 1212415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimum follow-up time required for the estimation of statistical cure of cancer patients: verification using data from 42 cancer sites in the SEER database.
    Tai P; Yu E; Cserni G; Vlastos G; Royce M; Kunkler I; Vinh-Hung V
    BMC Cancer; 2005 May; 5():48. PubMed ID: 15904508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodology to predict long-term cancer survival from short-term data using Tobacco Cancer Risk and Absolute Cancer Cure models.
    Mould RF; Lederman M; Tai P; Wong JK
    Phys Med Biol; 2002 Nov; 47(22):3893-924. PubMed ID: 12476973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival rates of laryngeal cancer patients treated by radiation and surgery, radiation alone, and surgery alone: studied by lognormal and Kaplan-Meier survival methods.
    Tai P; Yu E; Shiels R; Tonita J
    BMC Cancer; 2005 Jan; 5():13. PubMed ID: 15683543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second Primary Head and Neck Cancers After Non-Head and Neck Primary Cancers.
    Schlieve T; Heidel RE; Carlson ER
    J Oral Maxillofac Surg; 2016 Dec; 74(12):2515-2520. PubMed ID: 27292523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
    Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
    BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head and neck cancer in South East England between 1995-1999 and 2000-2004: An estimation of incidence and distribution by site, stage and histological type.
    Doobaree IU; Landis SH; Linklater KM; El-Hariry I; Moller H; Tyczynski J
    Oral Oncol; 2009 Sep; 45(9):809-14. PubMed ID: 19251472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced diffusion models in head and neck squamous cell carcinoma patients: Goodness of fit, relationships among diffusion parameters and comparison with dynamic contrast-enhanced perfusion.
    Fujima N; Sakashita T; Homma A; Shimizu Y; Yoshida A; Harada T; Tha KK; Kudo K; Shirato H
    Magn Reson Imaging; 2017 Feb; 36():16-23. PubMed ID: 27989906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival outcomes for second primary head and neck cancer: a matched analysis.
    Bhattacharyya N; Nayak VK
    Otolaryngol Head Neck Surg; 2005 Jan; 132(1):63-8. PubMed ID: 15632911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling procedure and surgical times for current procedural terminology-anesthesia-surgeon combinations and evaluation in terms of case-duration prediction and operating room efficiency: a multicenter study.
    Stepaniak PS; Heij C; Mannaerts GH; de Quelerij M; de Vries G
    Anesth Analg; 2009 Oct; 109(4):1232-45. PubMed ID: 19762753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basaloid squamous cell carcinoma of the head and neck.
    Paulino AF; Singh B; Shah JP; Huvos AG
    Laryngoscope; 2000 Sep; 110(9):1479-82. PubMed ID: 10983946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small cell carcinoma of the head and neck: the university of Miami experience.
    Hatoum GF; Patton B; Takita C; Abdel-Wahab M; LaFave K; Weed D; Reis IM
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):477-81. PubMed ID: 19004574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database.
    Carvalho AL; Nishimoto IN; Califano JA; Kowalski LP
    Int J Cancer; 2005 May; 114(5):806-16. PubMed ID: 15609302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head and neck cancer in the south west of England, Hampshire, and the Isle of Wight: trends in survival 1996-2008.
    Drugan C; Leary S; Mellor T; Bain C; Verne J; Ness A; Thomas S
    Br J Oral Maxillofac Surg; 2013 Jan; 51(1):19-24. PubMed ID: 22444947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma.
    Shin DM; Lee JS; Lippman SM; Lee JJ; Tu ZN; Choi G; Heyne K; Shin HJ; Ro JY; Goepfert H; Hong WK; Hittelman WN
    J Natl Cancer Inst; 1996 Apr; 88(8):519-29. PubMed ID: 8606380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of regenerating gene-I in patients with stage-IV head and neck squamous cell carcinoma.
    Aboshanif M; Kawasaki Y; Omori Y; Suzuki S; Honda K; Motoyama S; Ishikawa K
    Diagn Pathol; 2016 Aug; 11(1):79. PubMed ID: 27539087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.